Regeneron says Applied Medical's win against Medtronic backs US antitrust case against Amgen
( July 8, 2026, 19:50 GMT | Official Statement) -- MLex Summary: Regeneron told a US federal judge that Applied Medical's antitrust win against Medtronic supports its antitrust case against Amgen over cholesterol-reducing medication. Regeneron highlighted that the district court rejected Medtronic's argument that a jury must find each product in the bundle has monopoly or significant market power to be anticompetitive. See attached file....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.